Research programme: antibodies - Georgiamune
Alternative Names: GIM-1213sLatest Information Update: 25 Aug 2023
At a glance
- Originator Georgiamune
- Class Antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 22 Aug 2023 Early research in Unspecified in USA (Parenteral) before August 2023 (Georgiamune pipeline, August 2023)